L to R: Jeroen Bekaert, Ivan Dimov and Nate Fernhoff, Orca Bio (Orca)
A Bay Area upstart with legendary godfathers breaks cover, touting claims of a curative tech, unicorn status and a $300M plan to shoot for an approval
Back in the ‘90s, Sandoz — later Novartis — forged some big plans around an Irv Weissman startup called SyStemix. Isolating and purifying cells, the legendary Stanford …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.